Document is current
Any future updates will be listed below
-
Authors
Lam, Suzanne
Hérard, Anne-Sophie
Boluda, Susana
Petit, Fanny
Eddarkaoui, Sabiha
Cambon, Karine
,
Letournel, Franck
Martin-Négrier, Marie-Laure
Faisant, Maxime
Godfraind, Catherine
Boutonnat, Jean
Maurage, Claude-Alain
Deramecourt, Vincent
Duchesne, Mathilde
Meyronet, David
Fenouil, Tanguy
de Paula, André Mauès
Rigau, Valérie
Vandenbos-Burel, Fanny
Seilhean, Danielle
Duyckaerts, Charles
Boluda, Susana
Plu, Isabelle
Chiforeanu, Dan Christian
Laquerrière, Annie
Marguet, Florent
Lannes, Béatrice
Lhermitte, Benoît
Picq, Jean-Luc
Buée, Luc
Duyckaerts, Charles
Haïk, Stéphane
Dhenain, Marc http://orcid.org/0000-0001-8804-4101
-
Funding
Funding for this research was provided by:
Association France Alzheimer (InductAlz)
Agence Nationale de la Recherche (NeurATRIS - ANR-11-INBS-0011)
Ministère de l'Enseignement Supérieur, de la Recherche, et de l'Innovation (PhD Thesis)
Fondation pour la Recherche Médicale (PhD Thesis)
- License Information
-
More Information
Article History
Received: 18 May 2022
Accepted: 16 July 2022
First Online: 16 August 2022
Declarations
:
: All experimental procedures were conducted in accordance with the European Community Council Directive 2010/63/UE and approved by local ethics committees (CEtEA-CEA DSV IdF N°44, France) and the French Ministry of Education and Research (A17_083 authorization), and in compliance with the 3R guidelines. Animal care was supervised by a dedicated veterinarian and animal technicians. Human endpoints concerning untreatable continuous suffering signs and prostrations were used and not reached during the study.
: Does not apply to the content of this article.
: The authors declare that they have no competing interests.
